Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bar

Showing results (461-470 of 540) with videos related to

Pageof 54
Sort By:
International Journal of Molecular Sciences|January 28, 2026
SHIV.D Infection Alters Production and Protein Composition of Myeloid-Derived Extracellular VesiclesRachel M Podgorski, Amir Yarmahmoodi, Stephen Baak, et al.
Oncogene|December 9, 2008
Cancer cells suppress p53 in adjacent fibroblastsJ Bar, R Feniger-Barish, N Lukashchuk, et al.
Pathogens & Immunity|November 8, 2016
Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 GenomesJesus F Salazar-Gonzalez, Maria G Salazar, Damien C Tully, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
British Journal of Cancer|November 17, 2004
TP53 status determines clinical significance of ERBB2 expression in ovarian cancerJ Kupryjańczyk, R Madry, J Plisiecka-Hałasa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2023
Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIVChang Li, Anna Kate Anderson, Hongjie Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 7, 2023
Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIVChang Li, Anna Kate Anderson, Hongjie Wang, et al.
Medicine|February 13, 2016
Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, ChinaYang Jiao, Xiaoxi Zhang, Chen Wang, et al.
AIDS (London, England)|December 2, 2017
HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugsFan Li, Liying Ma, Yi Feng, et al.
The Journal of Infectious Diseases|October 23, 2024
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 AntibodiesMarie Høst Pahus, Yu Zheng, Maxine Olefsky, et al.
Pageof 54

Showing results (461-470 of 540) with videos related to

Sort By:
Pageof 54
International Journal of Molecular Sciences|January 28, 2026
SHIV.D Infection Alters Production and Protein Composition of Myeloid-Derived Extracellular VesiclesRachel M Podgorski, Amir Yarmahmoodi, Stephen Baak, et al.
Oncogene|December 9, 2008
Cancer cells suppress p53 in adjacent fibroblastsJ Bar, R Feniger-Barish, N Lukashchuk, et al.
Pathogens & Immunity|November 8, 2016
Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 GenomesJesus F Salazar-Gonzalez, Maria G Salazar, Damien C Tully, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
British Journal of Cancer|November 17, 2004
TP53 status determines clinical significance of ERBB2 expression in ovarian cancerJ Kupryjańczyk, R Madry, J Plisiecka-Hałasa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2023
Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIVChang Li, Anna Kate Anderson, Hongjie Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 7, 2023
Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIVChang Li, Anna Kate Anderson, Hongjie Wang, et al.
Medicine|February 13, 2016
Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, ChinaYang Jiao, Xiaoxi Zhang, Chen Wang, et al.
AIDS (London, England)|December 2, 2017
HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugsFan Li, Liying Ma, Yi Feng, et al.
The Journal of Infectious Diseases|October 23, 2024
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 AntibodiesMarie Høst Pahus, Yu Zheng, Maxine Olefsky, et al.
Pageof 54